Biogen

Biogen is a biotechnology company that specializes in the development and commercialization of therapies for neurological and neurodegenerative diseases. Founded in 1978, it has been a pioneer in research and innovation related to conditions such as multiple sclerosis, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. Biogen focuses on leveraging advanced technologies and scientific expertise to create treatments that improve the lives of patients suffering from serious medical conditions. The company is also involved in various collaborations and partnerships to enhance drug development and expand its therapeutics portfolio.